Variant Description
Genomic Description (hg38)
|
cDNA Description
|
Protein Description
|
Exon nb
|
CpG Site
|
Splice Site
|
Sequence Context
|
WT Codon
|
Mutant Codon
|
Effect
|
Effect Group3
|
g.7675071G>A |
c.541C>T |
p.R181C |
5-exon |
yes |
no |
G_G |
CGC |
TGC |
missense |
1 |
Predicted or Observed Splicing Effects on Main Transcript
Site Type
|
p53Site
|
WT Score
|
MUT Score
|
Variation
|
Source
|
|
- |
|
|
no significant change |
NNSPLICE 0.9 |
SpliceAI Predictions on Canonical Transcript (NM_000546.5) by
Jaganathan (2019) [ GitHub]
Delta Score_AG
|
Delta Score_AL
|
Delta Score_DG
|
Delta Score_DL
|
Delta Position_AG
|
Delta Position_AL
|
Delta Position_DG
|
Delta Position_DL
|
0 |
0.01 |
0.03 |
0 |
997 |
-117 |
28 |
265 |
Protein Features
Structural Motif
|
Domain Function
|
Residue Function
|
Cancer Hotspot
|
Variant Rate
|
SwissProt
|
L2/L3 |
DNA binding |
Exposed |
yes |
1.28 |
044946 |
Systematic Assessment of Transactivation Capacities in Yeast and Saos2 Assays by Kato
(2003) and Kakudo
(2005)
WAF1
|
MDM2
|
BAX
|
H1433s
|
AIP1
|
GADD45
|
NOXA
|
P53R2
|
WAF1 (Saos2)
|
MDM2 (Saos2)
|
BAX (Saos2)
|
h1433s (Saos2)
|
AIP1 (Saos2)
|
PUMA (Saos2)
|
43.1 |
21.7 |
18.6 |
9.4 |
21.0 |
51.3 |
70.2 |
128.0 |
|
|
|
|
|
|
Predicted or Observed Impacts on Protein Functions
Transactivation Class
|
DNE
|
DNE_LOF Class
|
Align-GVGD
|
BayesDel
|
REVEL
|
SIFT
|
Polyphen2
|
Structure Function
|
partially functional |
Moderate |
notDNE_notLOF |
C65 |
0.4693 |
0.891 |
Damaging |
D |
functional |
TAp53 Alpha
|
TAp53 Beta
|
TAp53 Gamma
|
Delta40p53 Alpha
|
Delta40p53 Beta
|
Delta40p53 Gamma
|
Delta133p53 Alpha
|
Delta133p53 Beta
|
Delta133p53 Gamma
|
Deltap53 Alpha
|
Altered |
Altered |
Altered |
Altered |
Altered |
Altered |
Altered |
Altered |
Altered |
Altered |
Various Activities Assessed in Yeast or Human Assays
Mouse Models Engineered with the Selected Mutant
No Data
Experimentally Induced Variants
Exposure
|
Model
|
PubMed
|
B(a)P-7,8-dione |
Yeast reporter gene assay |
23117049 |